Cooper Companies (The)

COO · NASDAQ · Health Care

$70.94▼ -0.11%

$0.08 today

Mkt cap $13.84B
P/E 60.1
Day $70.34 – $71.10

Confidence

High conviction

The read

Cooper Companies beats Q2 EPS estimates by 10%, shares rise 8.6%

Cooper Companies reported Q2 EPS of $1.21 versus $1.10 estimate, a 10% beat, driving an 8.6% stock price increase. Institutional ownership remains strong at 106%, with mixed growth metrics and solid valuation signals. Investors should monitor next quarter's EPS growth and margin trends for confirmation of sustainable improvement.

Confidence note: High confidence due to confirmed EPS beat, strong price reaction, and detailed fundamental metrics; limited by absence of explicit guidance.

What happened

Earnings print

Reported EPS of $1.21 beat the estimate of $1.10 by 10%.

Guidance

No explicit guidance provided in the payload; growth outlook mixed with 8.4% EPS next year forecast.

Price reaction

Shares rose 8.58% to $67.34 on heavy volume following the earnings beat.

Street narrative

Despite a 10% EPS beat, Cooper Companies shows mixed fundamental quality and growth metrics, with institutional ownership above 100% and a forward P/E 21% below sector average.

So what

What changed

Q2 EPS beat estimates by 10%, shares rose 8.6%, signaling positive market reaction.

What the market is pricing

Market is pricing improved near-term earnings strength reflected in strong post-earnings price gain.

Fundamental takeaway

Maintain current thesis with watch on next quarter EPS growth and margin trends for upgrade potential.

Next 30–90 days

Bull

42%

Sustained EPS growth above 8% and margin expansion drive multiple re-rating and share price appreciation.

Next quarter EPS growth exceeds 8.4% forecast
Operating margin improves beyond 11.8%

Base

39%

EPS growth remains near forecast with stable margins, supporting current valuation and moderate upside.

EPS growth in line with 8.4% next year forecast
Margins stable around 11-12%

Bear

19%

EPS growth disappoints and margins contract, leading to valuation multiple compression and share price decline.

Next quarter EPS growth below 5%
Operating margin falls below 10%

What to do

If you hold it

Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.

If you're watching

Add only if next-quarter guidance is reiterated or raised; avoid if guidance is cut or geopolitical risk escalates.

Keep on your radar

Next quarter EPS growth rate (due Q3 2026)
Operating margin trends in upcoming earnings
Institutional ownership changes over next 3 months
Stock price relative to 50-day and 200-day moving averages